The main objective of this session is to encourage papers and subsequent discussions that lead to development of the scientific foundation for forming building blocks such as particles, suspensions, granules, etc, consisting of pharmaceutical active ingredients with desired properties that improve the final product quality. Presentations dealing with development of science-based methodologies, processes, and formulations for forming materials engineered to have desired properties required for achieving ideal active substance delivery are encouraged. Major topics, include but are not limited to; formation and stabilization of particle suspensions, novel formulations to improve bioavailability of APIs, methods for particle functionalization and surface modification for optimizing and controlling physicochemical properties of materials that impact composite particle system performance.

Particle Production and Characterization

Pharmaceuticals (15b)